ACTU vs ON · $49.0M cap vs P/E 36, rev $3.12B
Actuate Therapeutics, Inc. Common stock (ACTU) versus ON Semiconductor Corporation (ON) — a side-by-side from cached financials, not a winner call.
Actuate Therapeutics, Inc. Common stock (ACTU) is a biotechnology company listed on NASDAQ.
ON Semiconductor Corporation (ON) is a semiconductors company listed on US.
ACTU does not have a complete income-statement cache yet.
Latest reported ON revenue for 2026-07-03 was $3.12B. Net income was $193.4M. ON currently screens at market cap $21.90B and trailing P/E 36.4.
ACTU currently screens at market cap $49.0M. ON currently screens at market cap $21.90B and trailing P/E 36.4.
Not investment advice. Open the ACTU and ON stock pages for the full models.
Not investment advice.